Interestingly, Galectin-9 (ref. 20), which was significantly increased in mouse cancer models (Supplementary Fig. 3) was also significantly increased in both of the PD-1-resistant patient cases as compared with untreated samples (Supplementary Fig. 7g). The gene discussed is PDCD1; the disease is cancer.